Response to Windahl et al
- PMID: 17080186
- PMCID: PMC1626133
- DOI: 10.1172/JCI30535
Response to Windahl et al
Comment on
-
Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor.J Clin Invest. 2006 Sep;116(9):2500-9. doi: 10.1172/JCI28809. J Clin Invest. 2006. PMID: 16955145 Free PMC article.
References
-
- Kousteni S., et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 2002;298:843–846. - PubMed
-
- Weinstein R.S., et al. The skeletal effects of glucocorticoid excess override those of orchidectomy in mice. Endocrinology. 2004;145:1980–1987. - PubMed
-
- Modder U.I., et al. Dose-response of estrogen on bone versus the uterus in ovariectomized mice. Eur. J. Endocrinol. 2004;151:503–510. - PubMed
-
- Hewitt S.C., Collins J., Grissom S., Hamilton K., Korach K.S. Estren behaves as a weak estrogen rather than a nongenomic selective activator in the mouse uterus. Endocrinology. 2006;147:2203–2214. - PubMed
